<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000635678">
  <TermName>ABVD</TermName>
  <TermDefinition>
    <DefinitionText>An abbreviation for a chemotherapy combination used to treat Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vinblastine sulfate, and dacarbazine. Also called ABVD regimen.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <SpanishTermName>ABVD</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de una quimioterapia combinada que se usa para el tratamiento del linfoma de Hodgkin. Incluye los medicamentos clorhidrato de doxorrubicina (Adriamycin), sulfato de bleomicina, sulfato de  vinblastina y dacarbazina. También se llama régimen ABVD.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2009-02-20</DateFirstPublished>
  <DateLastModified>2010-05-05</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000632567" url="/about-cancer/treatment/drugs/ABVD">ABVD</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
